206 related articles for article (PubMed ID: 35167270)
1. Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.
Papke RL; Andleeb H; Stokes C; Quadri M; Horenstein NA
ACS Chem Neurosci; 2022 Mar; 13(5):624-637. PubMed ID: 35167270
[TBL] [Abstract][Full Text] [Related]
2. New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
Dallanoce C; Richter K; Stokes C; Papotto C; Andleeb H; Thakur GA; Kerr A; Grau V; Papke RL
ACS Chem Neurosci; 2024 Feb; 15(4):827-843. PubMed ID: 38335726
[TBL] [Abstract][Full Text] [Related]
3. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.
Giraudo A; Pallavicini M; Bolchi C
Pharmacol Res; 2023 Jul; 193():106801. PubMed ID: 37236412
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and
Richter K; Papke RL; Stokes C; Roy DC; Espinosa ES; Wolf PMK; Hecker A; Liese J; Singh VK; Padberg W; Schlüter KD; Rohde M; McIntosh JM; Morley BJ; Horenstein NA; Grau V; Simard AR
Front Cell Neurosci; 2022; 16():779081. PubMed ID: 35431807
[TBL] [Abstract][Full Text] [Related]
5. α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain.
Shelukhina I; Siniavin A; Kasheverov I; Ojomoko L; Tsetlin V; Utkin Y
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047495
[TBL] [Abstract][Full Text] [Related]
6. Silent agonists for α7 nicotinic acetylcholine receptors.
Papke RL; Quadri M; Gulsevin A
Pharmacol Res; 2023 Apr; 190():106736. PubMed ID: 36940890
[TBL] [Abstract][Full Text] [Related]
7. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
[TBL] [Abstract][Full Text] [Related]
8. The Antinociceptive and Anti-Inflammatory Properties of the
Quadri M; Bagdas D; Toma W; Stokes C; Horenstein NA; Damaj MI; Papke RL
J Pharmacol Exp Ther; 2018 Nov; 367(2):203-214. PubMed ID: 30111636
[TBL] [Abstract][Full Text] [Related]
9. From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue.
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Eaton B; Lucero L; Gotti C; Moretti M; Whiteaker P; Bolchi C
J Med Chem; 2022 Jul; 65(14):10079-10097. PubMed ID: 35834819
[TBL] [Abstract][Full Text] [Related]
10. Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages.
Tan Y; Chu Z; Shan H; Zhangsun D; Zhu X; Luo S
Mar Drugs; 2022 Mar; 20(3):. PubMed ID: 35323499
[TBL] [Abstract][Full Text] [Related]
11. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
[TBL] [Abstract][Full Text] [Related]
12. α9-containing nicotinic acetylcholine receptors and the modulation of pain.
Hone AJ; Servent D; McIntosh JM
Br J Pharmacol; 2018 Jun; 175(11):1915-1927. PubMed ID: 28662295
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profiles and anti-inflammatory activity of pCN-diEPP and mCN-diEPP, new alpha9alpha10 nicotinic receptor ligands.
Richter K; Herz SM; Stokes C; Damaj MI; Grau V; Papke RL
Neuropharmacology; 2023 Dec; 240():109717. PubMed ID: 37758018
[TBL] [Abstract][Full Text] [Related]
14. A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors.
Hone AJ; Whiteaker P; Christensen S; Xiao Y; Meyer EL; McIntosh JM
J Neurochem; 2009 Oct; 111(1):80-9. PubMed ID: 19650873
[TBL] [Abstract][Full Text] [Related]
15. Mammalian nicotinic receptors with alpha7 subunits that slowly desensitize and rapidly recover from alpha-bungarotoxin blockade.
Cuevas J; Berg DK
J Neurosci; 1998 Dec; 18(24):10335-44. PubMed ID: 9852571
[TBL] [Abstract][Full Text] [Related]
16. A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE.
Godin JR; Roy P; Quadri M; Bagdas D; Toma W; Narendrula-Kotha R; Kishta OA; Damaj MI; Horenstein NA; Papke RL; Simard AR
Brain Behav Immun; 2020 Jul; 87():286-300. PubMed ID: 31874200
[TBL] [Abstract][Full Text] [Related]
17. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
[TBL] [Abstract][Full Text] [Related]
18. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
19. Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
Zwart R; Strotton M; Ching J; Astles PC; Sher E
Eur J Pharmacol; 2014 Mar; 726():77-86. PubMed ID: 24485886
[TBL] [Abstract][Full Text] [Related]
20. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
